Associations Between Three Polymorphisms in the Interleukin-4 Receptor Gene and Risk of Cancer: A Meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6227-6232

  Wang, Jia Yi ^a   Zhou, Yu Qiao ^a   Li, Xiao Xu ^a   Jin, Xin ^a   Wang, Li Li ^a   Lei, Lei ^a   Zhou, Yu ^a   Lu, Jiang ^a   Zeng, Xin ^a   Dan, Hong Xia ^a   Liao, Ga ^a   Chen, Qian Ming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer; Interleukin 4 receptor; Meta analysis; Polymorphisms

Indexed keywords

INTERLEUKIN 4 RECEPTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-4; RISK FACTORS;

EID: 84877067891     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6227     Document Type: Article

References (34)

1. Ali KS, Ali HY, Jubrael JM (2012). Concentration levels of IL-10 and TNF alpha cytokines in patients with human papilloma virus (HPV) DNA(+) and DNA(-) cervical lesions. J Immunotoxicol, 9, 168-72.
2. Ames BN, Gold LS, Willett WC (1995). The causes and prevention of cancer. Proc Natl Acad Sci USA, 92, 5258-65.
3. Balasubramanian SP, Azmy IA, Higham SE, et al (2006). Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer, 6, 188.
4. Brenner AV, Butler MA, Wang SS, et al (2007). Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis, 28, 2543-7.
5. Brown EE, Lan Q, Zheng T, Zhang Y, et al (2007). Common variants in genes that mediate immunity and risk of multiple myeloma. Int. J. Cancer, 120, 2715-22.
6. Castro FA, Haimila K, Sareneva I, et al (2009). Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. Int. J. Cancer, 125, 1851-8.
7. Chu H, Ma L, Wang M, Shi D, et al (2012). The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study. Mol Biol Rep, 39, 5349-57.
8. Chu H, Wang M, Yan F, et al (2012). Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma. Ann. Oncol, 23, 2114-21.
9. de Visser KE, Eichten A, Coussens LM (2006). Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer, 6, 24-37.
10. Engle LJ, Simpson CL, Landers JE (2006). Using high-throughput SNP technologies to study cancer. Oncogene, 25, 1594-601.
11. Gooch JL, Christy B, and Yee D (2002). STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. Neoplasia, 4, 324-31.
12. Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99.
13. Hamajima N, Matsuo K, Saito T, et al (2001). Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev, 2, 99-107.
14. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
15. Ivansson EL, Gustavsson IM, Magnusson JJ, et al (2007). Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer, 121, 2451-7.
16. Johnson LG, Schwartz SM, Malkki M, et al (2011). Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol. Biomarkers Prev, 20, 199-207.
17. Mitsuyasu H, Izuhara K, Mao XQ, et al (1998). Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet, 19, 119-20.
18. Mohan S, Mohanasenthil, Paul SF, Shroff S, Venkatesan V (2009). Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. Asian Pac J Cancer Prev, 10, 295-8.
19. Nakamura E, Megumi Y, Kobayashi T, et al (2002). Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. Clin. Cancer Res, 8, 2620-5.
20. Obiri NI, Hillman GG, Haas GP, Sud S, Puri RK (1993). Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest, 91, 88-93.
21. Obiri NI, Siegel JP, Varricchio F, Puri RK (1994). Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol, 95, 148-55.
22. Olson SH, Orlow I, Simon J, et al (2007). Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev, 31, 345-51.
23. Onishi T, Ohishi Y, Imagawa K, Ohmoto Y, Murata K (1999). An assessment of the immunological environment based on intratumoral cytokine production in renal cell carcinoma. BJU Int, 83, 488-92.
24. Ruan Z, Zhao Y, Yan L, et al (2011). Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma. Front Biosci, 3, 33-45.
25. Sarpatwari A, Bussel JB, Ahmed M, et al (2011). Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults. Hematology, 16, 243-8.
26. Schwartzbaum J, Ahlbom A, Malmer B, et al (2005). Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res, 65, 6459-65.
27. Schwartzbaum JA, Ahlbom A, Lonn S, et al (2007). An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol. Biomarkers Prev, 16, 2448-54.
28. Seno H, Satoh K, Tsuji S, et al (2007). Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J. Gastroenterol. Hepatol, 22, 729-37.
29. Sheu BC, Chang WC, Cheng CY, et al (2008). Cytokine regulation networks in the cancer microenvironment. Front Biosci, 13, 6255-68.
30. Sim SH, Ahn YO, Yoon J, et al (2012). Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer. Cancer Sci, 103, 155-60.
31. Wei BB, Xi B, Wang R, et al (2010). TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies. Cancer Genet Cytogenet, 196, 68-75.
32. Welsh MM, Karagas MR, Kuriger JK, et al (2011). Genetic determinants of UV-susceptibility in non-melanoma skin cancer. PLoS One, 6, e20019.
33. Wilkening S, Tavelin B, Canzian F, et al (2008). Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis, 29, 1202-06.
34. Xia HZ, Du WD, Wu Q, et al (2011). E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population. Mol Carcinog, 51, 597-607.